MOBILion Systems to Present Transformative Advances in Proteomics Sensitivity and Throughput at HUPO 2025

MOBILion Systems, Inc.

November 4, 2025

•

x min read

CHADDS FORD, Pa., Nov. 4, 2025 /PRNewswire/ -- MOBILion Systems, Inc., a leader in separation science innovation, announced today its participation in the 24th Annual Human Proteome Organization (HUPO) World Congress, taking place November 9–13, 2025, in Toronto, Canada. MOBILion's Chief Technology Officer, Daniel DeBord, Ph.D., will present new findings on Parallel Accumulation Mobility Aligned Fragmentation (PAMAF™), a breakthrough technique, unique to MOBILion, that dramatically improves mass spectrometry (MS) sensitivity and throughput for proteomics and multi-omics workflows.

Read Full Article

MOBILion Partners with Investigators at the Complex Carbohydrate Research Center at the University of Georgia for COVID-19 Glycan Analysis

MOBILion Systems Unveils Novel SLIM-based Ion Mobility Product at virtual ASMS conference 2020

SelectScience Article Ranks MOBILion’s SLIM Third Among Six Top Technologies at the American Society for Mass Spectrometry Reboot Conference

MOBILion Announces First-half 2020 Momentum and Corporate Achievements

MOBILion Closes $35M Series B Financing Round

MOBILion and International Research Team are Awarded Grant from The Michael J. Fox Foundation and the Shake it Up Australia Foundation to Resolve Biomarkers for Parkinson’s Disease

MOBILion Systems and Protein Metrics join forces to integrate the Byos® Software Suite with High-Resolution Ion Mobility Mass Spectrometry and Accelerate Biotherapeutic Characterization Workflows

Advancing Effective Glycan Analysis

SLIM-based HRIM-MS: the future of challenging separations

Analytical Scientist - Lipids on the Brain

Case study: New technology in COVID research may accelerate vaccines

SLIM Technology Set to Boost Biological Compound Analysis

Six Key Differentiators Between Liquid Chromatography and High-Resolution Ion Mobility

Rapid Glycan Analysis using High-Resolution Ion Mobility Mass Spectrometry

Enabling advancements in research of biomarkers

MOBILion Systems Launches MOBIE®: The First SLIM-Based High-Resolution Ion Mobility (HRIM) Product to Accelerate Biotherapeutic Drug Development and Multiomic Biomarker Discovery

MOBILion Systems Inc. Announces $60 Million Series C Financing Round Led by D1 Capital Partners to Expand Commercial Activities and Accelerate Product Development

MOBILion Systems Inc. Announces $60 Million Series C Financing Round Led by D1 Capital Partners to Expand Commercial Activities and Accelerate Product Development

Pushing the Proteomics Envelope

SLIM: A Gateway to the Adoption of High-Resolution Ion Mobility for Biotherapeutic Peptide Mapping

MOBILion Systems Rolls Out Red Carpet For MOBIE® at Hometown American Society For Mass Spectrometry Event

MOBILion Systems Rolls Out Red Carpet For MOBIE At Hometown American Society For Mass Spectrometry Event

C&EN's 2021 10 Start-Ups to Watch

Will the Real SLIM Please Stand Up?

Effectiveness of HighResolution Ion Mobility for Complex Analyses

Mobilion Expands Applications For Mobie And Highlights New Research At ASMS 2022

MOBILion Systems Appoints Jenn Buechel to its Board of Directors

MOBILion Systems Demonstrates Integration of SLIM Technology with Orbitrap Technology Yielding Sensitivity Gains

Cedars Sinai Team Develops Method for Quantitative Label-Free Proteomics Without LC Separation

Rilas Technologies and MOBILion Systems Announce Partnership to Expand Analytical Offering with High Resolution Ion Mobility

MOBILion Systems to Expand Applications of SLIM Separation Technology with License to TOFWERK AG

MOBILion Announces Joint Research Collaboration to be Conducted with EPA for PFAS Analysis

MOBILion to Showcase Innovations in Separation Science - New Capabilities and Application Workflows at ASMS 2023

2023 Best Tech Startups in Pennsylvania

CFO of the Year Awards 2023: Craig Carra, MOBILion Systems

MOBILion Partners with BOKU Vienna to Introduce High-Resolution Ion Mobility in Europe

Queen's University Belfast and MOBILion Announce Collaboration to Advance Food Safety

MOBILion Systems, Inc. Expands European Presence to Support MOBIE Instrument Sales and Customer Success

MOBILion Unveils Cutting-Edge Innovations For MOBIE® System and Showcases Pioneering Separations Science Advancements at ASMS 2024

MOBILion Announces Appointment of Analytical Instrumentation Veteran Rohit Khanna, Ph.D. to its Board of Directors

MOBILion Systems Unveils Novel High Resolution Mass Spectrometry Functionality Representing a Paradigm Shift in Speed and Sensitivity for Proteomics Workflows

MOBILion Systems Launches Proteomics Advisory Board

MOBILion Systems Partners with Leading Researcher at University of Duisburg-Essen to Advance Metabolomics Research and Discovery

MOBILion Systems Announces the 100th Peer-Reviewed Publication Featuring Its Separations Technology Platform

MOBILion Systems to Present Advanced Proteomics Capabilities with New PAMAF Operating Mode at US HUPO 2025

MOBILion Systems to Highlight Customer Use Cases from its MOBIE® Platform and Unveil Plans for their Next Generation Proteomics Platform at ASMS 2025

SLIM-IMS and PTR-TOF – The perfect Match for Real-Time Isomer Separation

MOBILion Systems to Present Transformative Advances in Proteomics Sensitivity and Throughput at HUPO 2025

Schedule a Chat Today!

MOBILion Wave Hero

MOBILion is the exclusive licensee of the SLIM technology for commercialization purposes. For research use only. Not for diagnostic procedures. MOBIE, MOBILion and REVEALING WHAT OTHERS LEAVE UNSEEN are registered trademarks of MOBILion Systems, Inc.